Medvarsity Logo
Thumbnail for Screening and Prevention of Colorectal Cancer

CASE DISCUSSION

Screening and Prevention of Colorectal Cancer

Nigeria flagPresented Nigeria by Dr. Evaristus Sunday Chukwudike

Views

176

Case Description

Colorectal cancer remains a critical concern in clinical practice, ranking as the third most diagnosed malignancy and the second leading cause of cancer-related mortality worldwide. Its development typically follows a well-characterized adenoma-carcinoma sequence that spans 10 to 15 years,...

Case Summary

  • Colorectal cancer represents a significant global health burden, currently standing as the third most diagnosed malignancy and the second leading cause of cancer-related mortality worldwide. The disease frequently progresses through a well-documented adenoma-carcinoma sequence, a process that typically spans 10 to 15 years, offering a critical window for intervention. While incidence rates have stabilized or declined in many high-income regions due to robust screening, there is a concerning rise in incidence within low- and middle-income countries, particularly across Africa, where presentation often occurs at a younger age.

Speaker Profile

Dr. Evaristus Sunday Chukwudike

Dr. Evaristus Sunday Chukwudike

Gastroenterology
Consultant Gastroenterologist and Hepatologist and Director of Endoscopy, Redus Center for Digestive Health, Lagos, Nigeria.

Disclosures

Assimilate by Medvarsity requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.